Afraid to Buy AI Stocks at These Valuations? Consider This Energy Play Instead

Cameco, the world’s second-largest uranium producer (17% of 2024 global production), is positioned to benefit from rising nuclear demand as data-center and low-carbon energy needs grow; it owns the world’s highest-grade and largest high-grade uranium mines in Canada and holds a 49% stake in Westinghouse. Despite a 15% revenue dip in Q3 2025, Cameco’s first nine months of 2025 showed 17% revenue growth and a 31% gross profit surge, with a net income margin of 15.18%, five-year revenue CAGR of 10.28% (three-year CAGR 24.18%); favorable U.S. policy (DOE capacity goals, $80bn Westinghouse procurement) and a 10% tariff carve-out for Canadian energy support further upside as global uranium demand is forecast to rise ~28% by 2030 with 70 reactors under construction and 115 planned.

Analysis

Market structure: Nuclear upside is structural — CCJ (17% of global supply) and integrated suppliers (Westinghouse stake) are direct beneficiaries as WNA forecasts +28% uranium demand to 2030 and 70 reactors under construction. Pricing power should improve if new mine supply and secondary inventories don’t accelerate; expect upward pressure on spot and long-term contract pricing over 12–36 months, benefiting vertically integrated producers while pressuring pure-play enrichment/fabrication where capacity is constrained.

Risk assessment: Tail risks include a major reactor incident, sudden policy reversals (domestic tariff or subsidy removal), or rapid Kazatomprom output restoration that floods markets; any of these could knock spot prices >25% in weeks. Time horizons: news-driven volatility in days/weeks (policy announcements, quarterly results), contract rollovers and mine ramps in months, structural demand realization over years (3–10 years). Hidden dependencies: fuel fabrication/enrichment bottlenecks and secondary stock releases; monitor Kazakh output and uranium spot inventory data monthly.

Trade implications: Primary trade is selective long CCJ exposures with options to cap downside — CCJ should outperform undifferentiated uranium ETFs if company execution holds. Consider 9–18 month bullish option structures to capture reactor procurement waves while limiting premium risk; rotate modest allocations out of high-momentum AI (eg. NVDA) into nuclear/commodity exposure to reduce concentration risk. Expect cross-asset: stronger uranium should be mildly positive for inflation-sensitive commodities and could steepen risk premia in credit for smaller miners.

Contrarian angles: Consensus underestimates project execution risk and secondary supply volatility — remember the 2007–2011 uranium bust where fundamentals reversed price mania. The market may be underpricing downside scenarios (25–40% drops) if inventory releases or Kazakh production accelerate; conversely long-term demand could be even higher if US/Europe accelerate reactor builds, making CCJ a valuable asymmetric play if you size positions defensively.

Key Decisions for Investors

• Establish a core long position in Cameco (CCJ) equal to 2–3% of portfolio over 4–8 weeks (DCA), add up to +1% on any >8% pullback; target hold 12–24 months and trim to take profits at +40% or if net margin falls below 10% or WNA demand revisions drop below +10% by 2030.
• Implement a 9–18 month bullish call spread on CCJ (buy a ~15–25% OTM LEAP call, sell a higher strike) sized to 0.5–1% notional to capture upside while limiting premium; close if spread >+100% or CCJ trades >30% above entry.
• Pair trade: go long CCJ (1.0x) versus short broad uranium ETF URA (0.5x) to express producer-specific upside and hedge spot-inventory shocks; rebalance if divergence exceeds 15% relative performance or if URA flows indicate >50k lb/month inventory release.
• Risk-manage broader tech exposure: reduce NVDA/NVDA-linked momentum exposure by ~20% of current weight if >5% portfolio concentration and redeploy proceeds into CCJ/uranium trades; monitor DOE and US tariff statements in next 30–90 days as binary catalysts.